Ultra‐Fast Insulin–Pramlintide Co‐Formulation for Improved Glucose Management in Diabetic Rats

Dual‐hormone replacement therapy with insulin and amylin in patients with type 1 diabetes has the potential to improve glucose management. Unfortunately, currently available formulations require burdensome separate injections at mealtimes and have disparate pharmacokinetics that do not mimic endogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Maikawa, Caitlin L., Chen, Peyton C., Vuong, Eric T., Nguyen, Leslee T., Mann, Joseph L., d'Aquino, Andrea I., Lal, Rayhan A., Maahs, David M., Buckingham, Bruce A., Appel, Eric A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564421/
https://www.ncbi.nlm.nih.gov/pubmed/34499434
http://dx.doi.org/10.1002/advs.202101575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564421/
https://www.ncbi.nlm.nih.gov/pubmed/34499434
http://dx.doi.org/10.1002/advs.202101575

Ejemplares similares